Zhejiang Shengda Pharm (603079) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.27 Million ≈ $6.62 Million USD) by net assets (CN¥1.60 Billion ≈ $234.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Shengda Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Zhejiang Shengda Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Shengda Pharm debt and liabilities for a breakdown of total debt and financial obligations.
Zhejiang Shengda Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shengda Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kerry TJ Logistics Co Ltd
TW:2608
|
0.062x |
|
Investors Title Company
NASDAQ:ITIC
|
0.019x |
|
WideOpenWest Inc
NYSE:WOW
|
0.264x |
|
Symtek Automation Asia Co Ltd
TW:6438
|
0.008x |
|
Sampoerna Agro Tbk
JK:SGRO
|
0.037x |
|
HiVi Acoustics Technology Co Ltd
SHE:002888
|
0.013x |
|
San Fu Chemical Co Ltd
TW:4755
|
0.044x |
|
Inzone Group Co Ltd
SHG:600858
|
0.186x |
Annual Cash Flow Conversion Efficiency for Zhejiang Shengda Pharm (2012–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shengda Pharm from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 603079 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.28 Billion ≈ $187.89 Million |
CN¥147.88 Million ≈ $21.64 Million |
0.115x | +127.05% |
| 2023-12-31 | CN¥1.27 Billion ≈ $185.84 Million |
CN¥64.42 Million ≈ $9.43 Million |
0.051x | +67.37% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.59 Million |
CN¥40.72 Million ≈ $5.96 Million |
0.030x | -45.58% |
| 2021-12-31 | CN¥1.34 Billion ≈ $195.64 Million |
CN¥74.46 Million ≈ $10.90 Million |
0.056x | -77.85% |
| 2020-12-31 | CN¥1.33 Billion ≈ $193.90 Million |
CN¥333.20 Million ≈ $48.76 Million |
0.251x | +291.54% |
| 2019-12-31 | CN¥911.71 Million ≈ $133.41 Million |
CN¥58.55 Million ≈ $8.57 Million |
0.064x | -40.01% |
| 2018-12-31 | CN¥828.42 Million ≈ $121.22 Million |
CN¥88.69 Million ≈ $12.98 Million |
0.107x | -13.68% |
| 2017-12-31 | CN¥768.71 Million ≈ $112.49 Million |
CN¥95.33 Million ≈ $13.95 Million |
0.124x | -25.25% |
| 2016-12-31 | CN¥440.02 Million ≈ $64.39 Million |
CN¥73.00 Million ≈ $10.68 Million |
0.166x | -50.80% |
| 2015-12-31 | CN¥439.09 Million ≈ $64.25 Million |
CN¥148.07 Million ≈ $21.67 Million |
0.337x | +218.46% |
| 2014-12-31 | CN¥324.87 Million ≈ $47.54 Million |
CN¥34.40 Million ≈ $5.03 Million |
0.106x | -71.73% |
| 2013-12-31 | CN¥281.09 Million ≈ $41.13 Million |
CN¥105.28 Million ≈ $15.41 Million |
0.375x | -36.72% |
| 2012-12-31 | CN¥185.99 Million ≈ $27.22 Million |
CN¥110.08 Million ≈ $16.11 Million |
0.592x | -- |
About Zhejiang Shengda Pharm
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.